If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
971.00    9.00 (0.94%)
Bid:
970.00
Ask:
974.00
Spread: 4.00 (0.412%)
Market Cap: £914.55m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

17 Oct 2013 07:00

RNS Number : 6606Q
Polar Capital Holdings PLC
17 October 2013
 



17 October 2013

 

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Group AUM (unaudited)

 

As at 30 September 2013 the Group's AUM increased by 58% to $11.4bn from the $7.2bn reported at 31 March 2013. This also represents over a 100% increase in AUM from the $5.3bn reported at 30 September 2012.

 

The table below sets out the movements in the Group's AUM over the six month period:

 

AUM movement

Six months to 30 September 2013

Long only funds

$m

Alternative funds

$m

Total

$m

As at 31 March 2013

$6,371m

$837m

$7,208m

Net subscriptions

$3,239m

$6m

$3,245m

Market movement and performance

$916m

$39m

$955m

Total AUM at 30 September 2013

$10,526m

$882m

$11,408m

 

Comment

 

Polar Capital recorded $3.2bn of net inflows in its first half year with a surprisingly high level of inflows in the historically slower summer second quarter amounting to $1.4bn.

 

In the quarter just commenced the Group's UK team will be leaving Polar Capital. It is not currently expected that a replacement UK team will be recruited. This will result in an outflow (at current market levels) of $293m of AUM in the December quarter.

 

Our overall strategy continues to be based on the presence of ten to twelve world class investment teams. The departure of the UK team will leave ten teams in place leaving further scope to add additional teams should the opportunity arise.

 

Given the renewed uncertainly in markets over recent weeks we would expect the levels of net inflows to be less certain and possibly materially lower in the upcoming quarters notwithstanding the loss of the UK related assets. The Group believes that despite this qualification it remains well positioned to grow both assets and profitability further over the longer term.

 

 

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first six months of the Group's financial year. The majority of the Group's performance fees crystallise in the second half of the financial year.

 

Performance fees

net of staff allocations

Six months to

30 Sept 12

£m

Year to

31 Mar 13

(year-end)

£m

Six months to

30 Sept 13

£m

Received

£0.0m

£5.5m

£0.0m

Accrued but not yet earned in funds with year ends on or before the financial year end

£4.2m

n/a

£4.5m

Total net performance fees

£4.2m

£5.5m

£4.5m

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (CFO)

Canaccord Genuity - Nomad and Broker

Simon Bridges (QE)

Martin Green

Cameron Duncan

F T I Consulting

Neil Doyle

Jack Hickey

 

 

+44 (0)20 7227 2700

 

 

+44 (0)20 7523 8000

 

 

+44 (0)20 7269 7132

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFEKFEFDFFF
Date   Source Headline
22nd Jun 20207:00 amRNSGroup Audited Results for year ended 31 March 2020
18th Jun 202012:08 pmRNSSecond Price Monitoring Extn
18th Jun 202012:02 pmRNSPrice Monitoring Extension
5th Jun 202010:31 amRNSDirector/PDMR Shareholding
4th Jun 20207:16 amRNSNotice of Results
1st Jun 20207:00 amRNSTotal Voting Rights
19th May 20202:00 pmRNSIssue of Equity
12th May 202010:22 amRNSDirector/PDMR Shareholding
11th May 20201:15 pmRNSDirectorate Change
6th May 202011:36 amRNSHolding(s) in Company
4th May 20201:07 pmRNSIssue of Equity
4th May 202011:24 amRNSDirector/PDMR Shareholding
15th Apr 202012:00 pmRNSFund Termination
9th Apr 20204:26 pmRNSDirectorate Change
9th Apr 202012:02 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSAuM Update
7th Apr 20204:40 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSBoard Changes
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
12th Mar 20208:37 amRNSIssue of Equity
2nd Mar 20207:00 amRNSTotal Voting Rights
28th Feb 20204:41 pmRNSSecond Price Monitoring Extn
28th Feb 20204:36 pmRNSPrice Monitoring Extension
21st Feb 202011:51 amRNSForm 8.3 - Redde PLC
21st Feb 20209:59 amRNSIssue of Equity
20th Feb 20201:54 pmRNSForm 8.3 - Redde PLC
18th Feb 202011:14 amRNSForm 8.3 - Redde PLC
18th Feb 202010:28 amRNSChange of Auditor
17th Feb 20202:44 pmRNSForm 8.3 - Redde PLC
13th Feb 20202:37 pmRNSIssue of Equity
13th Feb 20207:00 amRNSTeam Acquisition
7th Feb 20201:09 pmRNSForm 8.3 - Redde PLC
6th Feb 20202:45 pmRNSForm 8.3 - Redde PLC
5th Feb 20202:33 pmRNSForm 8.3 - Redde PLC
3rd Feb 202011:14 amRNSBlock listing Interim Review
28th Jan 20201:06 pmRNSForm 8.3 - Redde PLC
22nd Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
21st Jan 20202:26 pmRNSForm 8.3 - Redde PLC
21st Jan 20202:12 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20202:01 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20201:37 pmRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.